Activity Release Date: February 9, 2022 Expiration Date: February 9, 2024

This module focuses on enhancing organizational capacity and provider readiness to treat opioid use disorder with buprenorphine-naloxone through reviewing how to recognize and diagnose OUD and differing treatment methodologies.

Learning Objectives

  • Detail how to treat OUD with buprenorphine/naloxone
  • List at least two justifications for the use of combination buprenorphine/naloxone as the standard of care for general use
  • List at least three methods for establishing community partnerships and promoting MOUD services in general medical settings
  • Describe the key principles of the medication first model
  • Discuss the benefit of adding psychosocial support to the treatment of patients receiving MOUD
  •  Employ appropriate urine toxicology strategies
  • Outline treatment considerations for patients with co-occurring psychiatric disorders
  • Explain how to conduct a Telehealth session for treatment of OUDs


Jointly provided by Postgraduate Institute for Medicine and HealthHIV

Estimated time to complete activity: 1.25 hours 
Audience: Providers
Credits Available: AMA, AAPA, ANCC, ASWB, ACPE, CPH 
UAN #JA4008162-9999-22-059-H04-P
Activity Type - Knowledge